Generic vs. Brand-Name Drugs: What the FDA Actually Says

"Is the generic just as good?" is one of the most common questions patients ask — and the FDA's answer is clear. This explainer walks through what generic equivalence actually guarantees, what is allowed to differ, and the rare situations where switching deserves a second look.

Everything here traces to the FDA Orange Book and FDA DailyMed labeling. Prices come from our catalog cross-checked against the CMS NADAC file.

What 'bioequivalent' means

To be approved, a generic must contain the same active ingredient, at the same strength, in the same dosage form, taken by the same route as the brand. It must also demonstrate bioequivalence — that it delivers the drug to the bloodstream at a comparable rate and extent. The FDA's standard requires the generic's key pharmacokinetic measures to fall within an 80–125% confidence window of the brand, which in practice produces near-identical real-world exposure.

What 'AB-rated' means in the Orange Book

The FDA publishes therapeutic-equivalence ratings in the Orange Book. An "AB" rating means the generic is both pharmaceutically equivalent and therapeutically interchangeable with the brand — the gold standard your pharmacist relies on when substituting. You can look up any drug's rating yourself in the Orange Book.

What's allowed to differ

Inactive ingredients — binders, fillers, dyes, and coatings — can differ between a generic and its brand, and between generic manufacturers. For the vast majority of people this makes no clinical difference. It can matter in narrow cases: someone with a specific dye allergy, celiac disease requiring gluten-free fillers, or sensitivity to a particular excipient may do better on a specific manufacturer's product.

The price difference

The savings are dramatic and consistent: generic atorvastatin is about 3% of the brand price, generic escitalopram about 3.5%. Same molecule, same effect, a fraction of the cost.

When to be a little careful

A small group of "narrow-therapeutic-index" drugs — where the difference between an effective and a harmful dose is small — warrant more care when switching, including between generic manufacturers. Examples often cited include warfarin, levothyroxine, and certain anti-seizure medications. This does not mean the generic is unsafe; it means consistency matters, so try to stay on the same manufacturer and monitor as your prescriber advises.

How generics get approved and made

A generic does not simply copy a brand drug and hit the shelf. The manufacturer files an Abbreviated New Drug Application with the FDA, demonstrating that its product contains the same active ingredient at the same strength and dosage form, and proving bioequivalence through controlled studies. The FDA also inspects the facilities that make the generic, holding them to the same manufacturing quality standards as brand plants. Only after clearing this review does the generic earn its therapeutic-equivalence rating and reach patients. This is why an AB-rated generic is not a knockoff or an approximation — it is a rigorously vetted product that the FDA considers interchangeable with the brand.

It is also worth understanding why generics are so much cheaper despite this scrutiny. The original manufacturer bore the enormous cost of discovering the drug and running the clinical trials that proved it works; a generic maker skips that and only has to prove its version matches. With several manufacturers often producing the same off-patent drug, competition pushes the price down toward the cost of production. The low price reflects the absence of monopoly and marketing costs, not any compromise in quality.

How to make sure you get the generic

Getting the generic is usually simple, but it does not always happen automatically. In most states, a pharmacist may substitute an AB-rated generic unless the prescriber has written "dispense as written" or you specifically request the brand. Still, mistakes happen and defaults vary, so the reliable approach is to ask directly: tell your prescriber you prefer the generic when one exists, and confirm at the pharmacy counter that the generic was dispensed. If you are handed a surprisingly high price, that is the moment to ask whether a generic is available — the answer frequently turns a several-hundred-dollar fill into a few dollars for the identical medication.

For the small set of narrow-therapeutic-index drugs, the guidance is slightly different: you still use the generic to save money, but you and your pharmacist aim to keep you on the same manufacturer's version for consistency, with monitoring as your prescriber directs. For everything else, the generic is simply the smart default.

The bottom line on generics

The evidence and the FDA's standards point to a simple conclusion: for the overwhelming majority of medications, an AB-rated generic delivers the same clinical effect as the brand at a small fraction of the price. Choosing the generic is not settling for less — it is paying only for the medicine, not for a brand name and its marketing. The rare exceptions, a handful of narrow-therapeutic-index drugs, call for consistency rather than avoidance. For everything else, ask for the generic, confirm you received it, and keep the savings that competition was designed to give you.

How BetterBuyRx helps

BetterBuyRx shows the brand and generic price side by side for every drug and flags the AB-rated generic, so you can see the savings at a glance. Look up atorvastatin or amlodipine to compare, or read our savings guide.